Raffinadery29
No, Johnson & Johnson’s vaccine is not ‘less effective’ – that’s why
A vial containing the Johnson & Johnson Janssen Covid-19 vaccine at Northwell Health South Shore University Hospital in Bay Shore, New York, USA, on Wednesday, March 3, 2021. President Biden said that Merck & Co. will help make Johnson & Johnson’s single-shot coronavirus vaccine, a collaboration between competitors aimed at increasing vaccinations, which will be able to deliver enough stock for every adult in the US by the end of May. Photographer: Johnny Milano / Bloomberg via Getty Images Nationwide, people are struggling with the weight of life during the coronavirus pandemic as they reflect on an entire year living under some sort of barrier. For many, the pandemic means working from home, having less physical contact with family and friends, and a complete change in the way they deal with everyday life in an effort to rid themselves and their loved ones of the deadly to protect virus. But there is hope for relief, now that a third vaccine has been approved by the Food and Drug Administration (FDA) for emergency use. Johnson & Johnson’s single dose COVID-19 vaccine is now being administered across the country for people aged 18 and over. Despite the fact that even more vaccines are now being made available to millions of people across the country, some are skeptical that the J&J vaccine is less effective than the two-dose vaccines Moderna and Pfizer, due to the lower efficacy. Media reports about the new vaccine have drawn attention to its effectiveness rate: 72% for Johnson & Johnson, compared to 94% for Moderna and 95% for Pfizer. But the lower rate should not discourage anyone from getting the single-dose vaccine, which according to The New York Times is as effective as the other two in preventing serious illnesses. The lower efficacy number of the J&J vaccine only refers to the ability to prevent all infections due to the transmission of the SARS-Cov-2 virus. While it may not be as good at preventing mild COVID cases, Johnson & Johnson’s single dose is just as successful as the other two at preventing the most severe cases of this virus, and this is the most important. For more context, the Johnson & Johnson vaccine is also more effective than the flu shot. According to the Centers for Disease Control and Prevention (CDC), “influenza vaccination reduces the risk of influenza disease by between 40% and 60% among the general population during seasons when most influenza viruses in circulation correspond well with the influenza vaccine. ” Dr. Robert Wachter, chair of the Department of Medicine at the University of California, San Francisco, told The New York Times that with one of the three vaccines: “There’s really no chance of you dying from COVID, which is breathtaking. . ” This is noteworthy as the virus has killed more than half a million people in the US in the past year. The purpose of any of the three vaccines is not to completely eradicate COVID-19, which is probably here. Instead, the hope is to turn the virus into something like a mild flu or cold while we try to bring about herd immunity, and in that sense, things are looking up. “When you think about what you want from a vaccine, you do not want to go to the hospital, and you certainly do not want to die,” Alex Gorsky, CEO and chairman of Johnson & Johnson, told CNBC’s Squawk Box said. “And what we’ve seen up to 100% efficiency in these parameters, again with a single shot.” Experts say they would recommend one of the three vaccines and suggest that people get the one that is first made available to them. It is our best possible tool to move past the pandemic. Lisa Lee, an infectious disease pathologist and public health ethicist at Virginia Tech, said last month that a third vaccination option significantly reduces the time it takes the U.S. to reach herd immunity. “Lee also noted that as more of the population is vaccinated, there is less chance of further mutations of the virus.” If we stop transmitting between people, we also stop the opportunity for mutation, “she told CNBC. After a long year in relative isolation, while people are sitting with the sadness of losing their old way of life and their loved ones and the uncertainty about what comes next, it is natural that they can question the effectiveness of a new vaccine. have had so many blows in the past year, but rest assured that if you have time for the vaccine and the Johnson & Johnson single dose shot is made available to you, it’s just another layer of protection for all of us. is it going with a little more R29 goodness here? I helped create the Johnson & Johnson vaccine Can everyone be vaccinated by May? In the fierce hunt for remaining vaccines